Comparative study of the efficacy of Ketorolac 15mg and 30mg in postoperative pain after cesarean section under spinal anesthesia : A randomized controlled trial
Article Sidebar
Main Article Content
Abstract
Objectives: To compare the efficacy of parenteral ketorolac 15mg and 30mg in postoperative pain management at 6 hours and within 24 hours after cesarean section under spinal anesthesia
Methods: This randomized controlled trial included 130 patients undergoing cesarean section under spinal anesthesia. Patients were divided into two groups: group A (n=65) received parenteral ketorolac 15mg and group B (n=65) received ketorolac 30mg. Pain scores were assessed using the Visual Analog Scale (VAS) at 6, 12, 18, and 24 hours postoperatively. If pain score more than 5, patient will received Tramadol or opioids injection. Patients demographics data, newborn , and side effects were also recorded. Statistical analytic with significant level at p< 0.05
Results: There were no significant differences in demographic characteristics, surgical characteristics, and pain scores between the two groups. Additionally, there were no significant differences in the mean pain scores within the first 24 hours postoperatively. No tramadol or opioids required in both groups.
Conclusions: Ketorolac 15mg can be use for postoperative cesarean section pain management.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความนิพนธ์ต้นฉบับจะต้องผ่านการพิจารณาโดยผู้ทรงคุณวุฒิที่เชี่ยวชาญอย่างน้อย 2 ท่าน แบบผู้ทรงคุณวุฒิ และผู้แต่งไม่ทราบชื่อกันและกัน (double-blind review) และการตีพิมพ์บทความซ้ำต้องได้รับการอนุญาตจากกองบรรณาธิการเป็นลายลักษณ์อักษร
ลิขสิทธิ์
ห้ามนำข้อความทั้งหมดหรือบางส่วนไปพิมพ์ เว้นว่าได้รับอนุญาตจากโรงพยาบาลเป็นลายลักษณ์อักษร
ความรับผิดชอบ
เนื้อหาต้นฉบับที่ปรากฏในวารสารเป็นความรับผิดชอบของผู้เขียน ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากเทคนิคการพิมพ์
References
American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics. 1994;93:137–50.
Bernard R. Fundamentals of biostatistics. 5th ed. Duxbury: Thomson Learning; 2000. p.308.
Choo V, Lewis S. Ketorolac doses reduced. Lancet. 1993;342(8863):109.
Chow SC, Shao J, Wang H. Sample size calculations in clinical research. 2nd ed. Boca Raton, FL: Chapman and Hall/CRC; 2003. p.59.
Cohen SE, Desai JB, Ratner EF, Riley ET, Halpern J. Ketorolac and spinal morphine for postcesarean analgesia. Int J Obstet Anesth. 1996;5:14–8.
Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108:776–89.
De Oliveira GS Jr, Agarwal D, Benzon HT. Perioperative single dose ketorolac to prevent postoperative pain: a meta-analysis of randomized trials. Anesth Analg. 2012;114(2):424–33.
Duttchen KM, Lo A, Walker A, McLuckie D, De Guzman C, Roman-Smith H, et al. Intraoperative ketorolac dose of 15mg versus the standard 30mg on early postoperative pain after spine surgery: A randomized, blinded, non-inferiority trial. J Clin Anesth. 2017;41:11–5.
Eidinejad L, Bahreini M, Ahmadi A, Yazdchi M, Thiruganasambandamoorthy V, Mirfazaelian H. Comparison of intravenous ketorolac at three doses for treating renal colic in the emergency department: A noninferiority randomized controlled trial. Acad Emerg Med. 2021;28(7):768–75.
Forestell B, Sabbineni M, Sharif S, Chao J, Eltorki M. Comparative effectiveness of ketorolac dosing strategies for emergency department patients with acute pain. Ann Emerg Med. 2023;82(5):615–23.
Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.
Kasemsin P, Suwannarurk K, Pongrojpaw D, Chanthasenanont A, Lertvutivivat S, Pattaraarchachai J, et al. Effect of intravenous ketorolac on postoperative pain after cesarean section: A randomized double-blinded controlled trial. J Med Assoc Thai. 2017;100(Suppl.5):S168–74.
National Institute of Child Health and Human Development. Ketorolac. In: Drugs and Lactation Database (LactMed®). 2024.
Kulo A, van de Velde M, van Calsteren K, Smits A, de Hoon J, Verbesselt R. Pharmacokinetics of intravenous ketorolac following caesarean delivery. Int J Obstet Anesth. 2012;21:334–8.
Lefchak B, Morgan D, Finch M, Madhok M, Raschka M. Ketorolac dose ceiling effect for pediatric headache in the emergency department. J Pediatr Pharmacol Ther. 2024;29(5):494–500.
Macario A, Lipman AG. Ketorolac in the era of cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs: a systematic review of efficacy, side effects, and regulatory issues. Pain Med. 2001;2(4):336–51.
Motov S, Yasavolian M, Likourezos A, Pushkar I, Hossain R, Drapkin J, et al. Comparison of intravenous ketorolac at three single-dose regimens for treating acute pain in the emergency department: A randomized controlled trial. Ann Emerg Med. 2017;70(2):177–84.
Rathmell JP, Viscomi CM, Ashburn MA. Management of non-obstetric pain during pregnancy and lactation. Anesth Analg. 1997;85(5):1074–87.
Soleyman-Zomalan E, Motov S, Likourezos A, Cohen V, Pushkar I, Fromm C. Patterns of ketorolac dosing by emergency physicians. World J Emerg Med. 2017;8(1):43–6.
Wischnik A, Manth SM, Lloyd J, Bullingham R, Thompson JS. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing. Eur J Clin Pharmacol. 1989;36(5):521–5.
Yurashevich M, Pedro C, Fuller M, Habib AS. Intra-operative ketorolac 15mg versus 30mg for analgesia following cesarean delivery: a retrospective study. Int J Obstet Anesth. 2020;44:116–21.
อนวัชชกุล ว. ประสิทธิผลของยาคีโตโลแลคเปรียบเทียบกับมอร์ฟีนในการระงับอาการปวดแผลหลังผ่าตัดคลอดด้วยวิธีดมยาสลบ. วารสารการแพทย์โรงพยาบาลอุดรธานี. 2562;27(3):240–8.
________________________________________
